新型コロナウイルス感染症における血管障害の原因を解明~血管内皮細胞の老化によるウイルス取り込み増加が重症化の原因のひとつだった~

ad

2025-07-29 北海道大学

北海道大学の研究で、老化した血管内皮細胞がACE2受容体を持たずとも新型コロナウイルス(SARS-CoV-2)を多く取り込み、強い炎症反応を引き起こすことが判明。老化細胞ではBSGタンパク質が高発現し、VEGF経路を介してウイルス取り込みが促進されていた。これが高齢者におけるCOVID-19の重症化要因の一つとされ、老化血管内皮を標的とした新たな治療法の可能性が示された。

新型コロナウイルス感染症における血管障害の原因を解明~血管内皮細胞の老化によるウイルス取り込み増加が重症化の原因のひとつだった~
本研究成果の概要図

<関連情報>

BSG/VEGFR2経路によって制御される老化血管内皮細胞によるSARS-CoV-2取り込みと炎症応答 SARS-CoV-2 uptake and inflammatory response in senescent endothelial cells are regulated by the BSG/VEGFR2 pathway

Yuya Sakurai, Yoichiro Fujioka, Nako Maishi, +10 , and Kyoko Hida
Proceedings of the National Academy of Sciences  Published:July 28, 2025
DOI:https://doi.org/10.1073/pnas.2502724122

Significance

Despite the established link between COVID-19 and vascular endothelial dysfunction, the underlying mechanisms remain poorly understood. Our study provides the direct evidence of angiotensin-convertingenzyme 2 (ACE2)-independent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) uptake in vascular endothelial cells (ECs), which is significantly enhanced in aging and triggers a proinflammatory response. We reveal a molecular pathway linking endothelial senescence to increased viral susceptibility and inflammatory pathology, explaining why aging is a major risk factor for severe COVID-19. These findings not only resolve a long-standing controversy regarding SARS-CoV-2 infection of ECs but also identify senescent ECs as a promising therapeutic target for mitigating severe COVID-19 complications.

Abstract

Aging is a risk factor for severe COVID-19, characterized by vascular endothelial dysfunction. Although possible susceptibility of vascular endothelial cells (ECs) to SARS-CoV-2 infection has been suggested, the details of entry into cells have not been clarified. Previously, we reported that in an aged mouse model of severe COVID-19, ECs show a massive viral uptake and inflammatory response. Here, we focused on the endocytic capacity of senescent ECs. We found that the senescent ECs showed high endocytic capacity and SARS-CoV-2 virus uptake. This triggers an nuclear factor-kappa B (NF-κB) pathway–mediated inflammatory response. Further, Basigin enhanced endocytosis in the senescent ECs by activating the intracellular vascular endothelial growth factor signaling. Thus, EC senescence is associated with enhanced SARS-CoV-2 endocytosis and subsequent vascular endothelial dysfunction. This could prove a potential target for treating severe COVID-19 in older adults.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました